Pasmant E - Search Results

1

Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options.

Tlemsani C, Larousserie F, De Percin S, Audard V, Hadjadj D, Chen J, Biau D, Anract P, Terris B, Goldwasser F, Pasmant E, Boudou-Rouquette P. Tlemsani C, et al. Among authors: pasmant e. Int J Mol Sci. 2023 Jan 10;24(2):1361. doi: 10.3390/ijms24021361. Int J Mol Sci. 2023. PMID: 36674874 Free PMC article. Review.

2

Detection and characterization of NF1 microdeletions by custom high resolution array CGH.

Pasmant E, Sabbagh A, Masliah-Planchon J, Haddad V, Hamel MJ, Laurendeau I, Soulier J, Parfait B, Wolkenstein P, Bièche I, Vidaud M, Vidaud D. Pasmant E, et al. J Mol Diagn. 2009 Nov;11(6):524-9. doi: 10.2353/jmoldx.2009.090064. Epub 2009 Sep 18. J Mol Diagn. 2009. PMID: 19767589 Free PMC article.

3

NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype.

Pasmant E, Sabbagh A, Spurlock G, Laurendeau I, Grillo E, Hamel MJ, Martin L, Barbarot S, Leheup B, Rodriguez D, Lacombe D, Dollfus H, Pasquier L, Isidor B, Ferkal S, Soulier J, Sanson M, Dieux-Coeslier A, Bièche I, Parfait B, Vidaud M, Wolkenstein P, Upadhyaya M, Vidaud D; members of the NF France Network. Pasmant E, et al. Hum Mutat. 2010 Jun;31(6):E1506-18. doi: 10.1002/humu.21271. Hum Mutat. 2010. PMID: 20513137 Free article.

4

Identification of genes potentially involved in the increased risk of malignancy in NF1-microdeleted patients.

Pasmant E, Masliah-Planchon J, Lévy P, Laurendeau I, Ortonne N, Parfait B, Valeyrie-Allanore L, Leroy K, Wolkenstein P, Vidaud M, Vidaud D, Bièche I. Pasmant E, et al. Mol Med. 2011 Jan-Feb;17(1-2):79-87. doi: 10.2119/molmed.2010.00079. Epub 2010 Sep 10. Mol Med. 2011. PMID: 20844836 Free PMC article.

5

Differential expression of CCN1/CYR61, CCN3/NOV, CCN4/WISP1, and CCN5/WISP2 in neurofibromatosis type 1 tumorigenesis.

Pasmant E, Ortonne N, Rittié L, Laurendeau I, Lévy P, Lazar V, Parfait B, Leroy K, Dessen P, Valeyrie-Allanore L, Perbal B, Wolkenstein P, Vidaud M, Vidaud D, Bièche I. Pasmant E, et al. J Neuropathol Exp Neurol. 2010 Jan;69(1):60-9. doi: 10.1097/NEN.0b013e3181c79bff. J Neuropathol Exp Neurol. 2010. PMID: 20010302

6

A severe neonatal presentation of factor II deficiency.

Pasmant E, Dumont B, Lacapere JJ, Dautzenberg MD, Bezeaud A. Pasmant E, et al. Eur J Haematol. 2011 Nov;87(5):464-6. doi: 10.1111/j.1600-0609.2011.01670.x. Epub 2011 Aug 11. Eur J Haematol. 2011. PMID: 21692854

7

ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS.

Pasmant E, Sabbagh A, Vidaud M, Bièche I. Pasmant E, et al. FASEB J. 2011 Feb;25(2):444-8. doi: 10.1096/fj.10-172452. Epub 2010 Oct 18. FASEB J. 2011. PMID: 20956613 Review.

8

A natural variant with a point mutation resulting in a homozygous Arg to His substitution at position 388 in prothrombin.

d'Audigier C, Pasmant E, Bournier O, Laurian Y, Guillin MC, Bezeaud A. d'Audigier C, et al. Among authors: pasmant e. Haematologica. 2008 May;93(5):799-800. doi: 10.3324/haematol.12520. Haematologica. 2008. PMID: 18450742 Free article. No abstract available.

9

RAS MAPK inhibitors deregulation in leukemia.

Pasmant E, Vidaud D, Ballerini P. Pasmant E, et al. Oncoscience. 2015 Dec 4;2(12):930-1. doi: 10.18632/oncoscience.274. eCollection 2015. Oncoscience. 2015. PMID: 26909356 Free PMC article. No abstract available.

10

VKORC1 and CYP2C9 genetic polymorphisms in hepatic or portal vein thrombosis.

Pasmant E, de Beauvoir C, Plessier A, Labreuche J, Bezeaud A. Pasmant E, et al. Thromb Res. 2010 Aug;126(2):e134-6. doi: 10.1016/j.thromres.2010.03.015. Thromb Res. 2010. PMID: 20434758 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters